Encision Inc. Announces Fiscal 2026 Fourth Quarter and Full Year Results 
Suja Life Announces Filing of Registration Statement for Proposed Initial Public Offering
OCEANSIDE, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Suja Life, Inc. today announced that it has filed a registration statement...
Matricis.ai Launches First U.S. Clinical Pilot of EndomAI for AI-Assisted Detection of Endometriosis with SimonMed
Collaboration marks the first clinical pilot of AI-assisted MRI analysis for endometriosis.Paris, France, April 10, 2026 (GLOBE NEWSWIRE) -- Matricis.ai,...
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026
Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2026 (Pursuant to Article L.233-8 II of the...
EssilorLuxottica: First-Quarter 2026 Revenue Conference Call Invitation
First-Quarter 2026 RevenueConference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, andMr GIORGIO IANNELLA, Head of Investor Relations,have the pleasure...
EUROBIO SCIENTIFIC : 2025 ANNUAL RESULTS
2025 ANNUAL RESULTS Annual revenue up 9% to €168 millionRoll-out of the Group’s strategy: Sales of proprietary products up 20%,...
Humber River Health Renames Wilson Site Hennick Humber Hospital Following Transformational $50 Million Gift
Landmark philanthropic investment from the Hennick Family Foundation will accelerate innovation and patient care at North America’s first fully digital...
Trinity Launches InsightsEDGE™ | Digital Twins — Generative AI Unlocks Always-On Intelligence for Life Sciences Commercial Teams
Trinity transforms decades of strategic expertise into dynamic, data-driven customer models that help life sciences organizations anticipate market shifts and...
Releaf Crosses 25,000 Patients With Record Revenue
The medical cannabis clinic that put patients first and built the UK's fastest-growing healthcare business doing itReleaf surpasses 25,000 patients...
Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months
CHICAGO, IL / ACCESS Newswire / April 10, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a...
Voting Results of Cosmo’s 2026 AGM
Dublin, Ireland--(Newsfile Corp. - April 10, 2026) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announced that its shareholders...
Clariane announces the success of its offering of €500 million of senior notes
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR...
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer’s Disease 6-Month NDA Submission
Financing secures path to first NDA submission for buntanetap6-Month symptomatic data readout anticipated Q1 2027Alzheimer’s disease Phase 3 trial 75%...
FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity
Preclinical models demonstrate potential to restore thymic function lost with aging reducing susceptibility to cancer, autoimmune diseases, infections, and reduced...
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- via AINewsWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement...
BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications
Targets $81B command-and-control and video analytics markets by 2030, driven by real-time situational awareness in defense environmentsNETANYA, Israel and REHOVOT,...
LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management
LifeMD expands its weight management program with the addition of Foundayo, offering eligible patients an oral alternative to injectable GLP-1...
Enovis to Host First Quarter 2026 Results Conference Call on May 7th
Dallas, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that...
Milestone Pharmaceuticals Announces RESET-PSVT Registry to Generate Real-World Evidence on CARDAMYST™ (etripamil) Nasal Spray in Patients With PSVT
Registry Study Design Presented at the Preventive Cardiovascular Nurses Association 2026 Cardiovascular Nursing SymposiumMONTREAL and CHARLOTTE, N.C., April 10, 2026...
Unyte Health Acquires Vital Links and Vital Sounds, Developers of Therapeutic Listening®
Unyte Health Acquires Vital Links and Vital Sounds This union brings together the most respected pioneers in listening therapy. DENVER,...
NeurAxis, Inc. Announces Preferred Stock Dividend
CARMEL, Ind., April 10, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology...